What is Embla Medical hf. (OSSFF)?

Embla Medical hf. (OSSFF) is a stock in the Healthcare sector, Medical - Devices industry. View full analysis on Stocks360.

What is the current price of OSSFF?

The current price of OSSFF is $4.53. Prices are updated in real time on Stocks360.

What is OSSFF's price-to-earnings (PE) ratio?

OSSFF's trailing twelve-month PE ratio is 18.33, based on current price and earnings per share data available on Stocks360.

What is OSSFF's market capitalization?

OSSFF's market capitalization is $1,933,114,992.00, placing it in the small-cap tier.

Embla Medical hf. (OSSFF)

Stock analysis · OTC · Healthcare · Medical - Devices

$4.53

Market Cap

$1.93B

PE (TTM)

18.33

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.46

Day Range

$4.53 – $5.11

52-wk Range

$4.15 – $5.33

Avg Volume

N/A

Volume

40.00

Embla Medical hf. (OSSFF) is a publicly traded company in the Healthcare sector. Latest price: $4.53. Market cap $1.93B. Trailing PE 18.33. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 12 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-10-30 · $4.80 2026-10-26 · $4.53 (-5.62%)

Earnings

Most Recent

Oct 20, 2026

EPS $0.06 vs est. $0.07

Missed by $0.01

Next Earnings

Feb 2, 2027

EPS estimate $0.07

Proprietary Signals

Signal snapshot temporarily unavailable.

About Embla Medical hf.

Embla Medical hf is a global enterprise dedicated to the orthopaedic sector. Its primary focus involves the conceptualization, progression, manufacturing, and international distribution of non-surgical orthopaedic solutions. The company's business activities are geographically divided into three main regions: the Americas; Europe, the Middle East, and Africa (EMEA); and the Asia-Pacific territory. Established in 1971 by Össur Kristinsson, Embla Medical hf maintains its corporate headquarters in Reykjavík, Iceland.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	18.33×
P/S (TTM)	1.73×
P/B	1.86×
PEG	0.82×
P/FCF (TTM)	14.63×
EV / EBITDA	10.58×
EV / Sales	2.14×
Earnings Yield	5.46%
Free Cash Flow Yield	6.84%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$2.13B
Revenue (TTM)	$995.06M
Net Income (TTM)	$94.15M
Free Cash Flow (TTM)	$128.21M
Net Debt	$407.62M
Working Capital	$96.89M
Gross Margin	59.14%
Operating Margin	14.03%
Net Margin	9.46%
Return on Equity	10.35%
Return on Invested Capital	7.35%